After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
BMRN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Biomarin Pharmaceutical Inc is $10.96B. A total of 2.99 million shares were traded on the day, compared to an average of 2.16M shares.
In the most recent transaction, Burkhart Erin sold 1,786 shares of BMRN for 59.31 per share on May 20 ’25. After the transaction, the GVP, Chief Accounting Officer now owns 14,173 company shares. In a previous transaction on May 20 ’25, Burkhart Erin bought 1,786 shares at 59.31 per share.
Among the insiders who sold shares, Hubbard Cristin disposed of 273 shares on May 02 ’25 at a per-share price of $64.92. This resulted in the EVP, Chief Commercial Officer holding 32,700 shares of BMRN after the transaction. In another insider transaction, Hubbard Cristin bought 273 shares at $64.92 per share on May 02 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BMRN has a high of $94.85 and a low of $52.93.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BMRN’s latest balance sheet shows that the firm has $1.01B in Cash & Short Term Investments as of fiscal 2021. There were $1.09B in debt and $546.50M in liabilities at the time. Its Book Value Per Share was $30.21, while its Total Shareholder’s Equity was $4.27B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMRN is Buy with a score of 4.56.
